COMPASS PATHWAYS PLC Capital Expenditures
COMPASS PATHWAYS PLC (CMPS) reported Capital Expenditures of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-02-27
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $0.00.
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for fiscal 2023 was $66.00K, a 88.93% decline from fiscal 2022.
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for fiscal 2022 was $596.00K, a 78.44% increase from fiscal 2021.
- COMPASS PATHWAYS PLC payments to acquire property, plant, and equipment for fiscal 2021 was $334.00K, a 154.96% increase from fiscal 2020.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $18.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $18.00K derived: sum of 3 quarters · filed 2025-02-27 | $37.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $18.00K derived: sum of 2 quarters · filed 2025-02-27 | $37.00K derived: sum of 3 quarters · filed 2025-02-27 | $66.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $18.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $37.00K derived: sum of 2 quarters · filed 2024-10-31 | $66.00K 10-Q · filed 2024-10-31 | $173.00K derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $48.00K 10-Q · filed 2024-08-01 | $155.00K derived: sum of 3 quarters · filed 2024-08-01 | $150.00K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $29.00K 10-Q · filed 2024-05-08 | $136.00K derived: sum of 2 quarters · filed 2024-05-08 | $131.00K derived: sum of 3 quarters · filed 2024-05-08 | $543.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $102.00K derived: sum of 2 quarters · filed 2024-02-29 | $514.00K derived: sum of 3 quarters · filed 2024-02-29 | $596.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $407.00K derived: sum of 2 quarters · filed 2023-11-02 | $489.00K 10-Q · filed 2023-11-02 | $582.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $494.00K 10-Q · filed 2023-08-03 | $587.00K derived: sum of 3 quarters · filed 2024-02-29 | $673.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $82.00K 10-Q · filed 2023-05-11 | $175.00K derived: sum of 2 quarters · filed 2024-02-29 | $261.00K derived: sum of 3 quarters · filed 2024-02-29 | $346.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $179.00K derived: sum of 2 quarters · filed 2024-02-29 | $264.00K derived: sum of 3 quarters · filed 2024-02-29 | $334.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $171.00K derived: sum of 2 quarters · filed 2022-11-03 | $241.00K 10-Q · filed 2022-11-03 | $268.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $155.00K 10-Q · filed 2022-08-04 | $182.00K derived: sum of 3 quarters · filed 2023-02-28 | $193.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $70.00K 10-Q · filed 2022-05-10 | $97.00K derived: sum of 2 quarters · filed 2023-02-28 | $108.00K derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | $27.00K derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | $38.00K derived: sum of 2 quarters · filed 2023-02-28 | $131.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $11.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-09 | $104.00K 6-K · filed 2021-11-09 | ||
| 2020-06-30 | $93.00K 6-K · filed 2021-08-11 | |||
| 2019-12-31 | $165.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |